Clinical Trials
26 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
Indiana University
A Study of ZW251 in Participants With Advanced Solid Tumors
Zymeworks BC Inc.
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
SONOKID
Assistance Publique - Hôpitaux de Paris
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Children's Oncology Group
JACOB
Children's National Research Institute
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Baylor College of Medicine
NYMC195
New York Medical College
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Seattle Children's Hospital
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nationwide Children's Hospital
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
PRESERVE
Loma Linda University
ASPIRE
Wake Forest University Health Sciences
Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Indiana University
Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.
Sun Yat-sen University
RAISN
Heinrich-Heine University, Duesseldorf
DACT-GCT
National Cancer Institute, Slovakia
GERMAN
N.N. Petrov National Medical Research Center of Oncology
P3BEP
University of Sydney
GIG-T
Gustave Roussy, Cancer Campus, Grand Paris
GD2-CAR T Cells for Pediatric Brain Tumours
Bambino Gesù Hospital and Research Institute
HGT-QoL
Gustave Roussy, Cancer Campus, Grand Paris
Multidisciplinary Approach to Fatigue
Jules Bordet Institute